Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

IISc said this discovery could help develop interventions that prevent tuberculosis bacteria from infecting their hosts.

HELENA, Mont. — On the third floor of the University of Montana’s Skaggs Building, researchers work on the building blocks of a better vaccine for one of the world’s most lethal infectious diseases — ...

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development. This ...

PARIS — Around 15 vaccine candidates are being developed in the battle against tuberculosis to compensate for the poor efficacy of the Bacillus Calmette-Guérin (BCG) vaccine. Three of these candidates ...

Scientists report a promising new approach to speed vaccine testing for TB. Each year, tuberculosis (TB) kills more people than any other infectious disease, falling out of the top spot only ...

An analysis of fungi collected from peat bogs has identified several species that produce substances toxic to Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis in humans. The ...